相关实验视频

Updated: Jul 21, 2025

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

具有TDP-43基因突变的iPSC衍生的运动神经元对氧化应激的特定脆弱性

Asako Onda-Ohto^1,2, Minami Hasegawa-Ogawa¹, Hiromasa Matsuno^1,2

¹Division of Regenerative Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan.

Molecular brain

|July 26, 2023

概括

在ALS模型中,TDP-43突变特别会损害运动神经元,增加它们对氧化应激的脆弱性. 聚合物形成似乎与ALS病理学有关,但并非如此.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
细胞生物学细胞生物学

背景情况:

肌缩侧面硬化症 (ALS) 是一种神经退行性疾病,预后不佳.
在ALS患者的神经元内,TAR DNA 结合蛋白 43 kDa (TDP-43) 经常被发现.
了解TDP-43在ALS发病过程中的作用对于开发有效治疗方法至关重要.

研究的目的:

为了研究TDP-43突变引起的人类细胞的特定病理变化.
分析TDP-43突变对ALS运动神经元退化的贡献.
在ALS模型中区分细胞死亡的直接原因和相关的病理特征.

主要方法:

利用CRISPR/Cas9基因编辑引入TDP-43突变进入人类诱导的多能干细胞 (iPSCs).
将iPSC分化为运动神经元和感觉神经元,以创建同源细胞模型.
在包括氧化应激在内的各种条件下评估细胞形态,TDP-43局部化和聚合,细胞死亡和拼接功能.

主要成果:

与感官神经元不同的是,TDP-43突变表达运动神经元在暴露于氧化应激 (过氧化) 时表现出增加的细胞死亡.
在TDP-43突变运动神经元的一个子集中观察到聚合物形成,这表明与ALS病理学的相关性.
该研究成功模拟了TDP-43在人类神经元中的突变特异性影响,为疾病机制提供了洞察力.

结论:

具有TDP-43突变的人类iPSC衍生的运动神经元对氧化应激具有特定的脆弱性.
在这个模型中,TDP-43聚合物形成可能与ALS病理有关,但不是细胞死亡的主要原因.
这项研究提供了基本知识,以了解ALS的发病过程,并指导针对TDP-43.3的治疗策略.

关键词:

肌缩性侧面硬化症 (AMLS) 是一种疾病.运动神经元运动神经元氧化应激是一种氧化应激.这就是 iPSC 的意义.

更多相关视频

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Published on: May 1, 2019

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.